Skip to content
healthcare.dev

ATORVASTATIN CALCIUM

NDC 87441-013, ATORVASTATIN CALCIUM, tablet, film coated, from Unit Dose Solutions, Inc..

Product NDC
87441-013
Status
Listed
Labeler
Unit Dose Solutions, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090548
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87441-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE40 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
87441-013-018744100130130 TABLET, FILM COATED in 1 BLISTER PACK (87441-013-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/53c06fa9-ec26-5fa6-e063-6294a90a337f

Use it

Look up 87441-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87441-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87441-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.